Search For "eli lilly"
Lilly signs pact with Natco to accelerate availability of baricitinib for
Updated : 5 years ago IST
New Delhi [India], May 17 (ANI): Eli Lilly and Company said on Monday it has issued an additional royalty-free, non-exclusive voluntary license to Natco Pharma, a local pharmaceutical manufacturer of generic medicines.
Read More
Lilly signs 3 more pacts to accelerate availability of baricitinib for Cov
Updated : 5 years ago IST
New Delhi [India], May 13 (ANI): Eli Lilly and Company said on Thursday it has issued additional royalty-free, non-exclusive voluntary licenses to Dr Reddy's Ltd, MSN Laboratories and Torrent Pharmaceuticals who will collaborate to accelerate and expand the availability of baricitinib in Ind
Read More
Dr Reddy's enters into licensing agreement with Eli Lilly for COVID-19 tre
Updated : 5 years ago IST
Hyderabad (Telangana) [India], May 12 (ANI): Dr Reddy's Laboratories on Tuesday said that it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company for the manufacture and commercialization of the drug baricitinib, in India.
Read More
Lilly signs pacts with Cipla, Lupin, Sun Pharma to accelerate availability
Updated : 5 years ago IST
New Delhi [India], May 10 (ANI): US pharmaceutical major Eli Lilly said on Monday it has issued royalty-free, non-exclusive voluntary licenses to Cipla, Lupin and Sun Pharmaceutical to accelerate and expand the availability of baricitinib in India for Covid-19 patients.
Read More
US revokes authorisation of one of Eli Lilly's COVID-19 monoclonal antibod
Updated : 5 years, 1 month ago IST
Washington [US], April 17 (ANI): The US Food and Drug Administration (FDA) said on Friday that it has revoked it emergency authorisation of Eli Lilly's COVID-19 monoclonal antibody treatment bamlanivimab when used on its own.
Read More
US approves emergency use of Eli Lilly's antibody cocktail for COVID-19 tr
Updated : 5 years, 3 months ago IST
Washington [US], February 10 (ANI): The US Food and Drug Administration (FDA) has granted an emergency use authorization to a monoclonal antibody cocktail made by pharmaceutical company Eli Lilly for treating coronavirus patients at high risk of developing severe COVID-19.
Read More
Glenmark receives one ANDA approval and two tentative ANDA approvals - Tad
Updated : 5 years, 5 months ago IST
Mumbai (Maharashtra)[India], December 31 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has received final approval by the United States Food & Drug Administration (U.S. FDA) for Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg and 2
Read More
US allows emergency use of Eli Lilly's COVID-19 antibody treatment
Updated : 5 years, 6 months ago IST
Washington DC [US], November 10 (ANI): The US Food and Drug Administration (FDA) has approved an emergency use authorisation (EUA) for American pharmaceutical company Eli Lilly's experimental COVID-19 antibody treatment called 'bamlanivimab' for non-hospitalised patients with mild-to-moderat
Read More
Eli Lilly pauses COVID-19 treatment trial for Safety Reasons
Updated : 5 years, 7 months ago IST
Washington [US], October 14 (ANI/Sputnik): The US pharmaceutical company Eli Lilly's late-stage trial of its leading monoclonal antibody treatment for the novel coronavirus has been paused by health regulators over potential safety concerns, CNBC reported.
Read More